Spectropolarimetry in the differential diagnosis of benign and malignant ovarian tumors

2018 ◽  
Author(s):  
Sergey B. Yermolenko ◽  
Olexander P. Peresunko ◽  
Ion Gruia
Keyword(s):  
Differential Diagnosis ◽  
Ovarian Tumors

Differential Diagnosis of Malignant Ovarian Tumors on CT Findings

1996 ◽  
Vol 35 (1) ◽  
pp. 101
Author(s):  
Young Chae Kim ◽  
Myung Hwan Yoon ◽  
Dal Mo Yang ◽  
Hyo Sun Chung ◽  
Hyung Sik Kim ◽  
...  
Keyword(s):  
Differential Diagnosis ◽  
Ovarian Tumors ◽  
Ct Findings

Preoperative Measurement of Cancer Antigen 125 (CA 125) in the Differential Diagnosis of Ovarian Tumors

1989 ◽  
Vol 28 (4) ◽  
pp. 471-473 ◽  
Author(s):  
O. Mogensen ◽  
B. Mogensen ◽  
A. Jakobsen ◽  
A. Sell
Keyword(s):  
Differential Diagnosis ◽  
Ovarian Tumors ◽  
Ca 125 ◽  
Cancer Antigen 125 ◽  
Cancer Antigen

Immunoexpression of Inhibin α Subunit, Inhibin/Activin βA Subunit and CD99 in Ovarian Tumors

2000 ◽  
Vol 124 (4) ◽  
pp. 563-569 ◽  
Author(s):  
Yoon-La Choi ◽  
Hy-Sook Kim ◽  
Geunghwan Ahn
Keyword(s):  
Differential Diagnosis ◽  
Granulosa Cell ◽  
Mucinous Carcinoma ◽  
Ovarian Tumors ◽  
Serous Carcinoma ◽  
Α Subunit ◽  
Stromal Tumors ◽  
Epithelial Tumors ◽  
Krukenberg Tumors ◽  
Sex Cord Stromal Tumors

Abstract Objective.—Anti–inhibin α and inhibin/activin βA subunit and anti-CD99 monoclonal antibodies (mAbs) have recently been demonstrated to be able to label ovarian granulosa cells; thus, they may be of value in the diagnosis of granulosa cell tumors. The present study aimed to determine what combination of these mAbs may be useful for the differential diagnosis of sex cord–stromal tumors of ovary. Design.—Immunohistochemical analyses with anti–inhibin α and inhibin/activin βA subunit antibody and anti-CD99 mAb were performed on 42 ovarian tumors, including sex cord–stromal tumors (29), ovarian epithelial cancers (10), and Krukenberg tumors (3). Results.—All sex cord–stromal tumors were positive for inhibin α subunit, and 17 cases (58.6%) of sex cord–stromal tumors were immunoreactive for inhibin/activin βA subunit. Epithelial tumors and Krukenberg tumors were all negative for inhibin/activin βA subunit except mucinous carcinoma, which showed strong cytoplasmic immunoreactivity. All sex cord–stromal tumors except one granulosa cell tumor showed membranous staining for CD99. A case of serous carcinoma and a case of mucinous carcinoma were positive for CD99, and the remaining epithelial tumors and Krukenberg tumor were all negative for CD99. Conclusions.—The results of immunohistochemical analysis, together with literature review, suggest that inhibin α subunit may be a useful diagnostic marker for sex cord–stromal tumor of the ovary. In addition, anti-CD99 antibody may be useful for the differential diagnosis between ovarian tumors. Inhibin/activin βA subunit has a limited usefulness in the differential diagnosis of ovarian tumor because of its wider immunoreactivity for both sex cord–stromal tumors and mucinous carcinomas. The differential diagnosis of sex cord–stromal tumors of the ovary would be better made with a combined use of both anti–inhibin α subunit and anti-CD99 mAbs.

scholarly journals Diagnosis and Management of Ovarian Tumor in Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome

2018 ◽  
Vol 2018 ◽  
pp. 1-6
Author(s):  
Yali Miao ◽  
Jirui Wen ◽  
Liwei Huang ◽  
Jiang Wu ◽  
Zhiwei Zhao
Keyword(s):  
Differential Diagnosis ◽  
Laparoscopic Surgery ◽  
Conservative Management ◽  
Ovarian Tumor ◽  
Imaging Techniques ◽  
Clinical Findings ◽  
Ovarian Tumors ◽  
Mrkh Syndrome ◽  
Diagnosis And Management ◽  
Relevant Case

In the most recent publications on Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, the uterine remnants and ovaries in patients may develop uterine remnant leiomyoma, adenomyosis, or ovarian tumor, and this can lead to problems in differential diagnosis. Here we summarize the diagnosis methods and available interventions for ovarian tumor in MRKH syndrome, with emphasis on the relevant clinical findings and illustrative relevant case. According to the clinical findings and illustrative relevant case, with the help of imaging techniques, ovarian tumors can be detected in the pelvis in patients with MRKH syndrome and evaluated in terms of size. Laparoscopy could further differentiate ovarian tumors into different pathological types. In addition, laparoscopic surgery not only is helpful for the diagnosis of MRKH combined ovarian tumor, but also has a good treatment role for excising ovarian tumor at the same time. Moreover, laparoscopic removals of ovarian tumor can be considered as a safe and reliable treatment for conservative management.

FSH and LH serum/tumor fluid ratios and malignant tumors of the ovary.

2004 ◽  
Vol 11 (2) ◽  
pp. 315-321 ◽  
Author(s):  
I Rzepka-G√≥rska ◽  
A Chudecka-G≈Çaz ◽  
B Kosmowska
Keyword(s):  
Ovarian Cancer ◽  
Differential Diagnosis ◽  
Malignant Tumors ◽  
Ovarian Tumors ◽  
Predictive Values ◽  
Epithelial Tumors ◽  
Ovarian Carcinogenesis ◽  
Benign Ovarian Tumors ◽  
Sensitivity Specificity

The aim of this work was to compare mean concentrations of gonadotropins in serum and fluid from malignant and benign ovarian tumors. We enrolled 126 patients diagnosed with malignant epithelial tumors (n=40), borderline epithelial tumors (n=14), benign cystadenomas (n=28) and simple cysts (n=44) of the ovary. Premenopausal and postmenopausal subgroups were formed in each group. The concentration of FSH and LH was measured in serum and tumor fluid and the serum/tumor fluid ratio was calculated. The results in each group were compared and the sensitivity, specificity, positive and negative predictive values were determined. Mean concentrations of both gonadotropins in ovarian cancer fluid were significantly higher than in the remaining groups (P ranged from <0.005 to <0.0001). Mean serum/fluid ratios were lowest in ovarian cancer (FSH=2.91, LH=4.19). Our findings support the hypothesis that gonadotropins are involved in ovarian carcinogenesis and suggest that gonadotropin serum/tumor fluid ratios could be of value in the differential diagnosis of functional and organic cysts of the ovary.

Role of osteopontin in differential diagnosis of ovarian tumors

2013 ◽  
Vol 39 (11) ◽  
pp. 1518-1525 ◽  
Author(s):  
Rafal Moszynski ◽  
Sebastian Szubert ◽  
Dariusz Szpurek ◽  
Slawomir Michalak ◽  
Stefan Sajdak
Keyword(s):  
Differential Diagnosis ◽  
Ovarian Tumors

scholarly journals Menopausal status strongly influences the utility of predictive models in differential diagnosis of ovarian tumors: An external validation of selected diagnostic tools

2014 ◽  
Vol 85 (12) ◽  
pp. 892-899 ◽  
Author(s):  
Rafał Moszyński ◽  
Patryk Zywica ◽  
Andrzej Wojtowicz ◽  
Sebastian Szubert ◽  
Stefan Sajdak ◽  
...  
Keyword(s):  
Differential Diagnosis ◽  
Predictive Models ◽  
Menopausal Status ◽  
External Validation ◽  
Ovarian Tumors ◽  
Diagnostic Tools
Sign in / Sign up

Export Citation Format

Share Document